"Stealth" tumors: Breast cancer cells shun NK-cells anti-tumor immunity.
Breast cancers (BCs) comprise heterogeneous subtypes of various prognoses. An active anti-tumor immune profile usually correlated with a better survival. Two current major challenges of BC research are to understand the inter-relations between BC and anti-tumor immunity, and to identify candidates whose targeting would contribute to enhance anti-tumor efficiency.
Centre d'Immunologie de Marseille-Luminy; Aix-Marseille Université; Campus du Luminy; Marseille, France ; Aix-Marseille Université; UMR 891; Marseille, France.
Emilie
E
Mamessier
François
F
Bertucci
Renaud
R
Sabatier
Daniel
D
Birnbaum
Daniel
D
Olive